Mevo Health offers two evidence-based GLP-1 medications for safe and sustainable weight loss. We provide both Tirzepatide and Semaglutide, with most people seeing stronger and faster results on Tirzepatide.
Available medications:
• Tirzepatide (similar active ingredient to Zepbound and Mounjaro)
• Semaglutide (similar active ingredient to Wegovy and Ozempic)
These medications can help:
• Lower appetite
• Reduce food cravings
• Improve blood sugar regulation
• Support steady and sustainable weight loss
Compounded Medication Disclaimer
Mevo Health partners with licensed U.S. pharmacies that operate in FDA-registered, FDA-inspected 503A and 503B compounding facilities.
The active pharmaceutical ingredients (APIs) used are sourced from FDA-approved manufacturers.
However, it’s important to understand:
Compounded semaglutide and tirzepatide are not FDA-approved medications.
They are custom-made formulations prepared in FDA-registered facilities that follow strict quality, sterility, and potency standards.
Compounding is used when commercially branded medications are in shortage or when a customized formulation is medically appropriate.
Your provider will determine which medication, dose, and formulation is right for you.